129 related articles for article (PubMed ID: 1829779)
1. Cyclosporine effect on anti-CD3 monoclonal antibody-stimulated mitogenesis, phorbol ester comitogenesis, and PGE2 production.
McMillen MA; Kharma B; Fuortes M; Schaefer HC; McGowan EA; Baumgarten WK; Hoover EM
J Surg Res; 1991 Jul; 51(1):66-71. PubMed ID: 1829779
[TBL] [Abstract][Full Text] [Related]
2. The effect of the CD28 activation pathway on the immunosuppressive action of cyclosporine.
Hess AD; Bright EC
Transplantation; 1991 Jun; 51(6):1232-40. PubMed ID: 1646506
[TBL] [Abstract][Full Text] [Related]
3. Human T cell activation: differential response to anti-CD28 as compared to anti-CD3 monoclonal antibodies.
Bjorndahl JM; Sung SS; Hansen JA; Fu SM
Eur J Immunol; 1989 May; 19(5):881-7. PubMed ID: 2544432
[TBL] [Abstract][Full Text] [Related]
4. Immobilized anti-CD5 together with prolonged activation of protein kinase C induce interleukin 2-dependent T cell growth: evidence for signal transduction through CD5.
Vandenberghe P; Ceuppens JL
Eur J Immunol; 1991 Feb; 21(2):251-9. PubMed ID: 1705509
[TBL] [Abstract][Full Text] [Related]
5. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo activated T cells display increased sensitivity to PGE2.
Sunder-Plassmann R; Majdic O; Knapp W; Holter W
Cell Immunol; 1991 Dec; 138(2):289-99. PubMed ID: 1657408
[TBL] [Abstract][Full Text] [Related]
7. Activation of cord T lymphocytes. II. Cellular and molecular analysis of the defective response induced by anti-CD3 monoclonal antibody.
Bertotto A; Gerli R; Lanfrancone L; Crupi S; Arcangeli C; Cernetti C; Spinozzi F; Rambotti P
Cell Immunol; 1990 May; 127(2):247-59. PubMed ID: 2139363
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 inhibits human T-cell proliferation after crosslinking of the CD3-Ti complex by directly affecting T cells at an early step of the activation process.
Vercammen C; Ceuppens JL
Cell Immunol; 1987 Jan; 104(1):24-36. PubMed ID: 2948675
[TBL] [Abstract][Full Text] [Related]
9. Activation of the CD3/T cell receptor (TcR) complex or of protein kinase C potentiate adenylyl cyclase stimulation in a tumoral T cell line: involvement of two distinct intracellular pathways.
Bihoreau C; Heurtier A; Enjalbert A; Corvaïa N; Bensussan A; Degos L; Kordon C
Eur J Immunol; 1991 Nov; 21(11):2877-82. PubMed ID: 1657616
[TBL] [Abstract][Full Text] [Related]
10. Human T cell activation induced by a monoclonal mouse IgG3 anti-CD3 antibody (RIV9) requires binding of the Fc part of the antibody to the monocytic 72-kDa high-affinity Fc receptor (FcRI).
Ceuppens JL; Van Vaeck F
Cell Immunol; 1989 Jan; 118(1):136-46. PubMed ID: 2521302
[TBL] [Abstract][Full Text] [Related]
11. Activation of human T lymphocytes by crosslinking of anti-CD3 monoclonal antibodies.
Dixon JF; Law JL; Favero JJ
J Leukoc Biol; 1989 Sep; 46(3):214-20. PubMed ID: 2788205
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2.
Elliott L; Brooks W; Roszman T
Cell Mol Neurobiol; 1993 Dec; 13(6):579-92. PubMed ID: 7910781
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination.
Elliott L; Brooks W; Roszman T
Cell Mol Neurobiol; 1992 Oct; 12(5):411-27. PubMed ID: 1334806
[TBL] [Abstract][Full Text] [Related]
14. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
Bartik MM; Bauman GP; Brooks WH; Roszman TL
Cell Immunol; 1994 Oct; 158(1):116-30. PubMed ID: 8087859
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of MAP-2 kinase activity in T lymphocytes by anti-CD3 or anti-Ti monoclonal antibody is partially dependent on protein kinase C.
Nel AE; Hanekom C; Rheeder A; Williams K; Pollack S; Katz R; Landreth GE
J Immunol; 1990 Apr; 144(7):2683-9. PubMed ID: 2156931
[TBL] [Abstract][Full Text] [Related]
16. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
Tadmori W; Reed JC; Nowell PC; Kamoun M
J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
[TBL] [Abstract][Full Text] [Related]
17. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes.
June CH; Ledbetter JA; Lindsten T; Thompson CB
J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699
[TBL] [Abstract][Full Text] [Related]
18. Multiple signal transduction pathways lead to extracellular ATP-stimulated mitogenesis in mammalian cells: II. A pathway involving arachidonic acid release, prostaglandin synthesis, and cyclic AMP accumulation.
Huang NN; Wang DJ; Gonzalez F; Heppel LA
J Cell Physiol; 1991 Mar; 146(3):483-94. PubMed ID: 1850750
[TBL] [Abstract][Full Text] [Related]
19. The anti-T cell monoclonal antibody 9.3 (anti-CD28) provides a helper signal and bypasses the need for accessory cells in T cell activation with immobilized anti-CD3 and mitogens.
Baroja ML; Lorre K; Van Vaeck F; Ceuppens JL
Cell Immunol; 1989 Apr; 120(1):205-17. PubMed ID: 2539266
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
